|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.32 USD | -4.35% |
|
0.00% | +133.63% |
Nektar Therapeutics (NasdaqGS:NKTR) submitted a non-binding proposal to acquire PureTech Health plc (LSE:PRTC) on October 6, 2022.
Price
|
Change
|
5d. change
|
Capi.
| ||
|---|---|---|---|---|---|
| 212.5 GBX | 0.00% | +2.41% | 717M | ||
| 1.32 USD | -4.35% | 0.00% | 242M | ||
| 1st Jan change | Capi. | |
|---|---|---|
| +133.63% | 242M | |
| +24.17% | 556B | |
| -6.33% | 354B | |
| +19.90% | 331B | |
| +7.95% | 296B | |
| +13.45% | 233B | |
| +6.04% | 201B | |
| -10.51% | 193B | |
| -12.26% | 143B | |
| -6.47% | 144B |
NEKTAR THERAPEUTICS 
